Selective filtering defect at the axon initial segment in Alzheimer's disease mouse models

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Axon pathology is a hallmark of Alzheimer's disease (AD).
• The axon initial segment (AIS) plays a crucial role in neuronal function and integrity.
• Dysregulation of AIS components is implicated in neurodegenerative diseases.

Purpose of the Study:

• To investigate the role of miR-342-5p in Alzheimer's disease (AD) pathology.
• To determine the impact of miR-342-5p on ankyrin G (AnkG) expression and AIS function.
• To evaluate the therapeutic potential of restoring AnkG in AD models.

Main Methods:

• Utilized cultured hippocampal neurons from AD mouse models.
• Assessed the effects of miR-342-5p on AnkG expression.
• Monitored AIS filtering of macromolecules.
• Examined the localization of ion channels (Nav 1.6) and receptors (NR2B).
• Administered exogenous AnkG to APP/PS1 mice.

Main Results:

• Increased miR-342-5p was found to down-regulate AnkG expression.
• Diminished AnkG led to defective AIS filtering of macromolecules.
• AnkG deficiency impaired Nav 1.6 channel localization and confined NR2B to somatodendritic compartments.
• Restoration of AnkG expression improved cognitive function in 12-month-old APP/PS1 mice.

Conclusions:

• miR-342-5p-mediated down-regulation of AnkG contributes to AIS dysfunction in AD.
• Impaired AIS filtering and AnkG deficiency are significant factors in AD pathogenesis.
• AnkG represents a potential therapeutic target for Alzheimer's disease.